APA (7th ed.) Citation

J, W., R, T., H, Y., X, C., Y, Y., Y, Z., . . . F, B. (2026). Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis. Lung cancer (Amsterdam, Netherlands), 217, 109465. https://doi.org/10.1016/j.lungcan.2026.109465

Chicago Style (17th ed.) Citation

J, Wang, et al. "Comparative Efficacy of Tarlatamab and Second-line Therapies in Extensive-stage Small Cell Lung Cancer: A Network Meta-analysis." Lung Cancer (Amsterdam, Netherlands) 217 (2026): 109465. https://doi.org/10.1016/j.lungcan.2026.109465.

MLA (9th ed.) Citation

J, Wang, et al. "Comparative Efficacy of Tarlatamab and Second-line Therapies in Extensive-stage Small Cell Lung Cancer: A Network Meta-analysis." Lung Cancer (Amsterdam, Netherlands), vol. 217, 2026, p. 109465, https://doi.org/10.1016/j.lungcan.2026.109465.